
A comprehensive examination of what we know as fact about fenbendazole and cancer, including medical papers and evidence, practical realities, financial costs, and unknowns. Educational resources only. Always consult a licensed oncologist
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 292 | Founded | 6 months ago | Last Issue | 5 days ago |
| Active | |||||

Laboratory data confirms that fenbendazole destroys cancer cells selectively without harming healthy tissue.
The repurposing of antiparasitic agents in oncology represents shorter development timelines, reduced development costs, and a higher translational success rate.
Antiparasitic protocols evaluated across 17 clinical case reports and patient testimonials.
Based on the methodological framework, recurring patterns, and proposed evidence upgrades, here are two formal clinical study protocol synopses tailored to (1) the Neoadjuvant Cohort and (2) the CNS / Brain Metastasis Cohort.
Subscribers, engagement, traffic and sponsorship for Fenbendazole & Cancer.
| Subscribers | Engagement | 79 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #64 | |
| #101 |
The writers behind this newsletter.
What does the science actually tell us about fenbendazole and cancer? All content is presented strictly for educational and informational purposes and is not intended as medical advice.
You can find recent issues that have been published by Fenbendazole & Cancer on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Fenbendazole & Cancer, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Fenbendazole & Cancer as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Fenbendazole & Cancer using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Fenbendazole & Cancer. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.